Latest Contracts News

Bioxyne Limited has raised its FY2025 revenue forecast to $25 million, driven by a remarkable 267% increase in first-half revenue and strong momentum from its subsidiary Breathe Life Sciences.

Nyrada Inc. reports promising preclinical results for its lead drug NYR-BI03, showing an 86% cardioprotective effect, alongside a strong financial position bolstered by a AU$3.29 million capital raise. The company has submitted its Phase Ia clinical trial package, setting the stage for human testing.

Talius Group reports a robust December quarter with $4.4 million revenue, positive operating cash flow, and a strategic $2.5 million capital raise, positioning the company for strong growth in 2025 amid evolving aged care legislation.

Cyprium Metals has partnered with Macmahon Holdings in a strategic alliance to accelerate the redevelopment of the Nifty Copper Complex, leveraging Macmahon’s operational expertise to advance feasibility studies and site operations.

Santana Minerals has reported a robust Pre-feasibility Study for its Bendigo-Ophir Gold Project, lifting the after-tax NPV to A$1.2 billion and IRR to 76%, as it progresses detailed engineering and fast-track permitting in New Zealand.

Hydrix Limited has extended its contract with Paul Hartmann AG, adding $2.8 million in revenue and reinforcing its international growth strategy.

Santos delivered a robust Q4 2024 with over US$1.4 billion in sales revenue and strong free cash flow, while progressing key LNG projects and expanding its decarbonisation initiatives.

Fortescue Metals Group has delivered its highest ever half-year iron ore shipments of 97.1 million tonnes, alongside a notable 10% reduction in hematite production costs, underscoring operational strength and advancing decarbonisation efforts.

InFocus Group Holdings reports $500,000 in cash receipts from the first phase of its VigoBet digital gaming platform contract, with the project nearing completion and promising further phases.

International Graphite Limited has locked in a $2 million government grant to fund critical feasibility studies for its Western Australian battery anode materials project, reinforcing its mine-to-market strategy.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

BPH Global has completed its acquisition of Indonesian seaweed assets, establishing a wholly owned subsidiary and launching joint operations aimed at expanding seaweed cultivation and bio-stimulant product development across Asia.